4Filing Date: May 6, 2026
West Pharmaceutical Services (WST)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000105770-26-000065
Total Value$0
Trades1
Insiders1
Transaction Details
Michels Douglas A
Director·Direct
Grant · Acquire
Common Stock
Shares+791
Price$0.00
Total Value$0
Shares Owned After46.50K
Transaction DateMay 4, 2026
Footnotes ▸
These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
Post-Transaction Holdings
Michels Douglas A · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 46.50K | +791 (1.73%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-04
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
--- Reporting Owner ---
Name: Michels Douglas A
CIK: 0001295391
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-04 | Code: A (Grant or award)
Shares: +791 | Price: $0.00
Shares Owned After: 46,495.55 | Ownership: D (Direct)
Footnotes:
[F1] These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
--- Footnotes (Complete Index) ---
F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
--- Signature ---
/s/ /s/ Louis Lalli, as an agent for Douglas A. Michels (2026-05-06)